SCHEMBL20079471

SCHEMBL20079471

COc1cc(C(=O)C(=O)NC(C)C)cc(OC)c1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.60
▸ ALOX12 P18054 1/20 0.60
▸ MAPK1 P28482 1/20 0.55
▸ GAA P10253 1/20 0.50
▸ MEN1 O00255 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ TUBB1 Q9H4B7 6/20 0.48
▸ TUBB4A P04350 2/20 0.45
▸ TUBB P07437 2/20 0.45
▸ TUBA3C P0DPH7 2/20 0.45
▸ TUBA1B P68363 2/20 0.45
▸ TUBA4A P68366 2/20 0.45
▸ TUBB4B P68371 2/20 0.45
▸ TUBB3 Q13509 2/20 0.45
▸ TUBB2A Q13885 2/20 0.45
▸ TUBB8 Q3ZCM7 2/20 0.45
▸ TUBA3E Q6PEY2 2/20 0.45
▸ TUBA1A Q71U36 2/20 0.45
▸ TUBA1C Q9BQE3 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13753811 0.84 ALDH1A1 (0.74) ALDH1A1ALOX12MAPK1GAAMEN1
SCHEMBL19460133 0.83 TAS1R3 (0.50) ALDH1A1ALOX12MAPK1MEN1KMT2A
SCHEMBL19465037 0.81 ALDH1A1 (0.54) ALDH1A1MAPK1MEN1KMT2AKDM4E
SCHEMBL4625442 0.80 TUBB1 (0.58) ALDH1A1MEN1KMT2AKDM4ETUBB1
SCHEMBL31679677 0.77 TUBB1 (0.54) ALDH1A1MAPK1MEN1KMT2AKDM4E
SCHEMBL31099233 0.75 MAPK1 (0.66) ALDH1A1ALOX12MAPK1MEN1KMT2A
SCHEMBL23734449 0.74 TUBB1 (0.55) ALDH1A1GAAMEN1KMT2AKDM4E
SCHEMBL907576 0.74 TPMT (0.56) ALDH1A1MEN1KMT2AKDM4ETUBB1
SCHEMBL20402962 0.73 ALDH1A1 (0.55) ALDH1A1ALOX12MAPK1MEN1KMT2A
SCHEMBL11740426 0.73 MAPK1 (0.62) ALDH1A1ALOX12MAPK1GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9951058-B2 Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient KATHOLIEKE UNIVERSITEIT LEUVEN K.U. LEUVEN R & D (BE) 2018-04-24 — — US disclosed
Send feedback